Status: Recruiting
Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
A prospective multicenter, single-arm phase II study enrolling treatment-naïve patients with metastatic pulmonary large-cell neuroendocrine carcinoma (LCNEC)
Participants needed: 49
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Gruppo Oncologico Italiano di Ricerca ClinicaUpdated: May 16, 2024Locations: 15
Eligibility criteria
Capable of giving signed informed consent which includes compliance with the req... [+6]
No need for concomitant chest irradiation [+56]